Journal of the Neurological Sciences 1996: Vol 139 Index

7 Pages·1996·1.8 MB·English

JOURNOAF LTH E
NEUROLOGICAL
SCIENCES
nAY
ELSEVIER
Journal of the Neurological Sciences 139 (1996) 246-248
Author Index (Vol. 139)
Agostino, R., Sanes, J.N. and Hallett, M. Ferrari, M.D., see Van der Kamp, W. (139) 106
Motor skill learning in Parkinson’s disease (139) 218 Figarella-Branger, D., see Bendahan, D. (139) 149
Akaike, M., see Mitsui, T. (139) 111 Finklestein, S.P., see Jiang, N. (139) 173
Allt, G., see Lawrenson, J.G. (139) 117 Finsterer, J., Muellbacher, W. and Mamoli, B.
Alonso, D.F., Farias, E.F., Famulari, A.L., Dominguez, R.O., Kohan, S. Yes/yes head tremor without appendicular tremor after bilateral
and De Lustig, E.S. cerebellar infarction (139) 242
Excessive urokinase-type plasminogen activator activity in the eu- Fioretti, C., see Bongioanni, P. (139) 71
globulin fraction of patients with Alzheimer-type dementia (139) 83 Fiszer, U., Fredrikson, S. and Cztonkowska, A.
Al Shahwan, S., Rossi, M.L.M. and Al Thagafi, M.A. Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in
Ascending paralysis due to myelitis in a newborn with congenital Parkinson’s disease (139) 66
toxoplasmosis (139) 156 Fredrikson, S., see Fiszer, U. (139) 66
Al Thagafi, M.A., see Al Shahwan, S. (139) 156 Fuchigami, Y., see Kaneko, K. (139) 131
Ambrogi, F., see Bongioanni, P. (139) 71 Fujimoto, Y., see Matsumura, R. (139) 52
Andrada-Serpa, M.J., Schor, D., Araiijo, A.Q.-C. and Rumjanek, V.M. Fujiwara, T., see Nagasawa, H. (139) 210
Immunological features of HTLV-I myelopathy in Rio de Janeiro, Fukuuchi, Y., see Tanahashi, N. (139) 137
Brazil, and in vitro effects of Cyclosporin A (139) 7 Fukuyama, H., see Ogawa, M. (139) 78
Araiijo, A.Q.-C., see Andrada-Serpa, M.J. (139) 7
Baethmann, A., see Mackert, B.-M. (139) 39 Ghabriel, M.N., see Lawrenson, J.G. (139) 117
Bartholomé, E., Manto, M., Jacquy, J. and Hildebrand, J. Goebel, H.H., see Schoser, B.G.H. (139) 203
Analysis of ballistic movements in ataxic hemiparesis following a
pontine stroke (139) 238 Hallett, M., see Agostino, R. (139) 218
Bendahan, D., Pouget, J., Pellissier, J.F., Figarella-Branger, D. and Heckman, H.M., see Myers, R.R. (139) 28
Cozzone, P.J. Hildebrand, J., see Bartholomé, E. (139) 238
Magnetic resonance spectroscopy and histological study of tubular Hirota, N., Kaji, R., Yoshikawa, H., Nishimura;, T., Ikeda, T., Yanagi-
aggregates in a familial myopathy (139) 149 hara, T. and Kimura, J.
Bengzon, J., see Uchino, H. (139) 21
Hereditary neuropathy with liability to pressure palsies: distinguishing
Bianchi, F., see Bongioanni, P. (139) 71
clinical and electrophysiological features among patients with multi-
Block, F., Schmitt, W. and Schwarz, M. ple entrapment neuropathy (139) 187
Pretreatment but not posttreatment with GYKI 52466 reduces func- Hoffman, E.K., Wilcox, H.M., Scott, R.W. and Siman, R.
tional deficits and neuronal damage after global ischemia in rats (139) Proteasome inhibition enhances the stability of mouse Cu/Zn super-
167
oxide dismutase with mutations linked to familial amyotrophic lateral
Bolton, C.F., see Zifko, U.A. (139) 197 sclerosis (139) 15
Bongioanni, P., Fioretti, C., Vanacore, R., Bianchi, F., Lombardo, F., Honda, M., Suwazono, S., Nagamine, T., Yonekura, Y. and Shibasaki, H.
Ambrogi, F. and Meucci, G. P300 abnormalities in patients with selective impairment of recent
Lymphocyte subsets in multiple sclerosis. A study with two-colour memory (139) 95
fluorescence analysis (139) 71 Horikawa, H., see Matsumura, R. (139) 52
Caday, C.G., see Jiang, N. (139) 173 Howells, D.W., Liberatore, G.T., Wong, J.Y.F. and Donnan, G.A.
Dopaminergic responses to striatal damage (139) 125
Ceuterick, C. and Martin, J.-J.
Sporadic early adult-onset distal myopathy with rimmed vacuoles:
immunohistochemistry and electron microscopy (139) 190 Ido, T., see Nagasawa, H. (139) 210
Charette, M., see Jiang, N. (139) 173 Ikeda, T., see Hirota, N. (139) 187
Chopp, M., see Jiang, N. (139) 173 Ito, T., see Kaneko, K. (139) 131
Chow, C.K., see Ragusa, R.J. (139) 180 Itoh, M., see Nagasawa, H. (139) 210
Chuma, T., see Matsumura, R. (139) 52 Itoyama, Y., see Nagasawa, H. (139) 210
Cozzone, P.J., see Bendahan, D. (139) 149 Iwata, M., see Sakurai, Y. (139) 89
Cztonkowska, A., see Fiszer, U. (139) 66 Iwata, R., see Nagasawa, H. (139) 210
De Lustig, E.S., see Alonso, D.F. (139) 83
Do, T., see Jiang, N. (139) 173 Jacquy, J., see Bartholomé, E. (139) 238
Dominguez, R.O., see Alonso, D.F. (139) 83 Jiang, N., Finklestein, S.P., Do, T., Caday, C.G., Charette, M. and
Donnan, G.A., see Howells, D.W. (139) 125 Chopp, M.
Delayed intravenous administration of basic fibroblast growth factor
Famulari, A.L., see Alonso, D.F. (139) 83 (bFGF) reduces infarct volume in a model of focal cerebral
Farias, E.F., see Alonso, D.F. (139) 83 ischemia /reperfusion in the rat (139) 173
JOURNOAF LTH E
NEUROLOGICAL
SCIENCES
nAY
ELSEVIER
Journal of the Neurological Sciences 139 (1996) 246-248
Author Index (Vol. 139)
Agostino, R., Sanes, J.N. and Hallett, M. Ferrari, M.D., see Van der Kamp, W. (139) 106
Motor skill learning in Parkinson’s disease (139) 218 Figarella-Branger, D., see Bendahan, D. (139) 149
Akaike, M., see Mitsui, T. (139) 111 Finklestein, S.P., see Jiang, N. (139) 173
Allt, G., see Lawrenson, J.G. (139) 117 Finsterer, J., Muellbacher, W. and Mamoli, B.
Alonso, D.F., Farias, E.F., Famulari, A.L., Dominguez, R.O., Kohan, S. Yes/yes head tremor without appendicular tremor after bilateral
and De Lustig, E.S. cerebellar infarction (139) 242
Excessive urokinase-type plasminogen activator activity in the eu- Fioretti, C., see Bongioanni, P. (139) 71
globulin fraction of patients with Alzheimer-type dementia (139) 83 Fiszer, U., Fredrikson, S. and Cztonkowska, A.
Al Shahwan, S., Rossi, M.L.M. and Al Thagafi, M.A. Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in
Ascending paralysis due to myelitis in a newborn with congenital Parkinson’s disease (139) 66
toxoplasmosis (139) 156 Fredrikson, S., see Fiszer, U. (139) 66
Al Thagafi, M.A., see Al Shahwan, S. (139) 156 Fuchigami, Y., see Kaneko, K. (139) 131
Ambrogi, F., see Bongioanni, P. (139) 71 Fujimoto, Y., see Matsumura, R. (139) 52
Andrada-Serpa, M.J., Schor, D., Araiijo, A.Q.-C. and Rumjanek, V.M. Fujiwara, T., see Nagasawa, H. (139) 210
Immunological features of HTLV-I myelopathy in Rio de Janeiro, Fukuuchi, Y., see Tanahashi, N. (139) 137
Brazil, and in vitro effects of Cyclosporin A (139) 7 Fukuyama, H., see Ogawa, M. (139) 78
Araiijo, A.Q.-C., see Andrada-Serpa, M.J. (139) 7
Baethmann, A., see Mackert, B.-M. (139) 39 Ghabriel, M.N., see Lawrenson, J.G. (139) 117
Bartholomé, E., Manto, M., Jacquy, J. and Hildebrand, J. Goebel, H.H., see Schoser, B.G.H. (139) 203
Analysis of ballistic movements in ataxic hemiparesis following a
pontine stroke (139) 238 Hallett, M., see Agostino, R. (139) 218
Bendahan, D., Pouget, J., Pellissier, J.F., Figarella-Branger, D. and Heckman, H.M., see Myers, R.R. (139) 28
Cozzone, P.J. Hildebrand, J., see Bartholomé, E. (139) 238
Magnetic resonance spectroscopy and histological study of tubular Hirota, N., Kaji, R., Yoshikawa, H., Nishimura;, T., Ikeda, T., Yanagi-
aggregates in a familial myopathy (139) 149 hara, T. and Kimura, J.
Bengzon, J., see Uchino, H. (139) 21
Hereditary neuropathy with liability to pressure palsies: distinguishing
Bianchi, F., see Bongioanni, P. (139) 71
clinical and electrophysiological features among patients with multi-
Block, F., Schmitt, W. and Schwarz, M. ple entrapment neuropathy (139) 187
Pretreatment but not posttreatment with GYKI 52466 reduces func- Hoffman, E.K., Wilcox, H.M., Scott, R.W. and Siman, R.
tional deficits and neuronal damage after global ischemia in rats (139) Proteasome inhibition enhances the stability of mouse Cu/Zn super-
167
oxide dismutase with mutations linked to familial amyotrophic lateral
Bolton, C.F., see Zifko, U.A. (139) 197 sclerosis (139) 15
Bongioanni, P., Fioretti, C., Vanacore, R., Bianchi, F., Lombardo, F., Honda, M., Suwazono, S., Nagamine, T., Yonekura, Y. and Shibasaki, H.
Ambrogi, F. and Meucci, G. P300 abnormalities in patients with selective impairment of recent
Lymphocyte subsets in multiple sclerosis. A study with two-colour memory (139) 95
fluorescence analysis (139) 71 Horikawa, H., see Matsumura, R. (139) 52
Caday, C.G., see Jiang, N. (139) 173 Howells, D.W., Liberatore, G.T., Wong, J.Y.F. and Donnan, G.A.
Dopaminergic responses to striatal damage (139) 125
Ceuterick, C. and Martin, J.-J.
Sporadic early adult-onset distal myopathy with rimmed vacuoles:
immunohistochemistry and electron microscopy (139) 190 Ido, T., see Nagasawa, H. (139) 210
Charette, M., see Jiang, N. (139) 173 Ikeda, T., see Hirota, N. (139) 187
Chopp, M., see Jiang, N. (139) 173 Ito, T., see Kaneko, K. (139) 131
Chow, C.K., see Ragusa, R.J. (139) 180 Itoh, M., see Nagasawa, H. (139) 210
Chuma, T., see Matsumura, R. (139) 52 Itoyama, Y., see Nagasawa, H. (139) 210
Cozzone, P.J., see Bendahan, D. (139) 149 Iwata, M., see Sakurai, Y. (139) 89
Cztonkowska, A., see Fiszer, U. (139) 66 Iwata, R., see Nagasawa, H. (139) 210
De Lustig, E.S., see Alonso, D.F. (139) 83
Do, T., see Jiang, N. (139) 173 Jacquy, J., see Bartholomé, E. (139) 238
Dominguez, R.O., see Alonso, D.F. (139) 83 Jiang, N., Finklestein, S.P., Do, T., Caday, C.G., Charette, M. and
Donnan, G.A., see Howells, D.W. (139) 125 Chopp, M.
Delayed intravenous administration of basic fibroblast growth factor
Famulari, A.L., see Alonso, D.F. (139) 83 (bFGF) reduces infarct volume in a model of focal cerebral
Farias, E.F., see Alonso, D.F. (139) 83 ischemia /reperfusion in the rat (139) 173
Author Index (Vol. 139)
Kaji, R., see Hirota, N. (139) 187 Nagamine, T., see Honda, M. (139) 95
Kakigi, R., see Matsui, M. (139) 235 Nagasawa, H., Tanji, H., Nomura, H., Saito, H., Itoyama, Y., Kimura, L.,
Kanazawa, I., see Sakurai, Y. (139) 89 Tuji, S., Fujiwara, T., Iwata, R., Itoh, M. and Ido, T.
Kaneko, K., Kawai, S., Fuchigami, Y., Shiraishi, G. and Ito, T. PET study of cerebral glucose metabolism and fluorodopa uptake in
Effect of stimulus intensity and voluntary contraction on corticospinal patients with corticobasal degeneration (139) 210
potentials following transcranial magnetic stimulation (139) 131 Nagasawa, M., see Mitsui, T. (139) 111
Kawai, H., see Mitsui, T. (139) 111 Namikawa, T., see Matsumura, R. (139) 48
Kawai, S., see Kaneko, K. (139) 131 Naoi, M., see Maruyama, W. (139) 141
Kempski, O., see Mackert, B.-M. (139) 39 Narabayashi, H., see Maruyama, W. (139) 141
Kihira, T., see Matsumura, R. (139) 48 Nickson, I., see McCombe, P.A. (139) 1
Kimura, I., see Nagasawa, H. (139) 210 Nishimura;, T., see Hirota, N. (139) 187
Kimura, J., see Hirota, N. (139) 187 Nomura, H., see Nagasawa, H. (139) 210
Kimura, J., see Ogawa, M. (139) 78 Notermans, S.L.H., see Van Domburg, P.H.M.F. (139) 58
Kimura, Y., see Mitsui, T. (139) 111
Kobari, M., see Tanahashi, N. (139) 137 Ogawa, M., Fukuyama, H., Ouchi, Y., Yamauchi, H. and Kimura, J.
Kohan, S., see Alonso, D.F. (139) 83 Altered energy metabolism in Alzheimer’s disease (139) 78
Kunishige, M., see Mitsui, T. (139) 111 Ouchi, Y., see Ogawa, M. (139) 78
Kuroda, Y., see Matsui, M. (139) 235
Pellissier, J.F., see Bendahan, D. (139) 149
Pender, M.P., see McCombe, P.A. (139) 1
Lawrenson, J.G., Reid, A.R., Ghabriel, M.N. and Allt, G.
Peters, J., see Mackert, B.-M. (139) 39
Dural microvessels: molecular properties of their luminal anionic sites
Porter, J.D., see Ragusa, R.J. (139) 180
(139) 117
Pouget, J., see Bendahan, D. (139) 149
Liberatore, G.T., see Howells, D.W. (139) 125
Powell, H.C., see Myers, R.R. (139) 28
Lombardo, F., see Bongioanni, P. (139) 71
Lundgren, J., see Uchino, H. (139) 21
Ragusa, R.J., Chow, C.K., St. Clair, D.K. and Porter, J.D.
Extraocular, limb and diaphragm muscle group-specific antioxidant
MaassenVanDenBrink, A., see Van der Kamp, W. (139) 106 enzyme activity patterns in control and mdx mice (139) 180
Mackert, B.-M., Staub, F., Peters, J., Baethmann, A. and Kempski, O. Reid, A.R., see Lawrenson, J.G. (139) 117
Anoxia in vitro does not induce neuronal swelling or death (139) 39 Reid, R.H., see Zifko, U.A. (139) 197
Mamoli, B., see Finsterer, J. (139) 242 Remtulla, H., see Zifko, U.A. (139) 197
Mano, Y., see Matsumura, R. (139) 48 Rossi, M.L.M., see Al Shahwan, S. (139) 156
Mano, Y., see Matsumura, R. (139) 52 Rumjanek, V.M., see Andrada-Serpa, M.J. (139) 7
Manto, M., see Bartholomé, E. (139) 238
Martin, J.-J., see Ceuterick, C. (139) 190 Saito, H., see Nagasawa, H. (139) 210
Maruyama, W., Naoi, M. and Narabayashi, H. Saito, S., see Mitsui, T. (139) 111
The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine Sakurai, Y., Momose, T., Iwata, M., Sasaki, Y. and Kanazawa, I.
and their effects on monoamines in the human brain: analysis of the Activation of prefrontal and posterior superior temporal areas in
intraventricular fluid from parkinsonian patients (139) 141 visual calculation (139) 89
Matsui, M., Kakigi, R., Watanabe, S. and Kuroda, Y. Sanes, J.N., see Agostino, R. (139) 218
Recurrent demyelinating transverse myelitis in a high titer HBs-anti- Sasaki, Y., see Sakurai, Y. (139) 89
gen carrier (139) 235 Schmitt, W., see Block, F. (139) 167
Matsumura, R., Namikawa, T., Miki, T., Kihira, T., Yamagata, H., Mano, Schor, D., see Andrada-Serpa, M.J. (139) 7
Y. and Takayanagi, T. Schoser, B.G.H. and Goebel, H.H.
An intergenerational contraction of the CTG repeat in Japanese Tenascin in denervated human muscle (139) 203
myotonic dystrophy (139) 48 Schwarz, M., see Block, F. (139) 167
Matsumura, R., Takayanagi, T., Fujimoto, Y., Murata, K., Mano, Y., Scott, R.W., see Hoffman, E.K. (139) 15
Horikawa, H. and Chuma, T. Shibasaki, H., see Honda, M. (139) 95
The relationship between trinucleotide repeat length and phenotypic Shiraishi, G., see Kaneko, K. (139) 131
variation in Machado-Joseph disease (139) 52 Siesjé, B.K., see Uchino, H. (139) 21
McCombe, P.A., Nickson, I., Tabi, Z. and Pender, M.P. Siman, R., see Hoffman, E.K. (139) 15
Apoptosis of V88.2* T lymphocytes in the spinal cord during Slomka, P.J., see Zifko, U.A. (139) 197
recovery from experimental autoimmune encephalomyelitis induced Smith, M.-L., see Uchino, H. (139) 21
in Lewis rats by inoculation with myelin basic protein (139) 1 Staub, F., see Mackert, B.-M. (139) 39
Meucci, G., see Bongioanni, P. (139) 71 St. Clair, D.K., see Ragusa, R.J. (139) 180
Miki, T., see Matsumura, R. (139) 48 Suwazono, S., see Honda, M. (139) 95
Mitsui, T., Kawai, H., Nagasawa, M., Kunishige, M., Akaike, M.,
Kimura, Y. and Saito, S. Tabi, Z., see McCombe, P.A. (139) 1
Oxidative damage to skeletal muscle DNA from patients with mito- Takayanagi, T., see Matsumura, R. (139) 48
chondrial encephalomyopathies (139) 111 Takayanagi, T., see Matsumura, R. (139) 52
Miyagi, F., see Yuki, N. (139) 160 Takeda, H., see Tanahashi, N. (139) 137
Momose, T., see Sakurai, Y. (139) 89 Tanahashi, N., Tomita, M., Kobari, M., Takeda, H., Yokoyama, M. and
Muellbacher, W., see Finsterer, J. (139) 242 Fukuuchi, Y.
Murata, K., see Matsumura, R. (139) 52 Aspirin improves the enhanced erythrocyte aggregability in patients
Myers, R.R., Heckman, H.M. and Powell, H.C. with cerebral infarction (139) 137
Axonal viability and the persistence of thermal hyperalgesia after Tanji, H., see Nagasawa, H. (139) 210
partial freeze lesions of nerve (139) 28 Ten Donkelaar, H.J., see Van Domburg, P.H.M.F. (139) 58
248 Author Index (Vol. 139)
Tomita, M., see Tanahashi, N. (139) 137 Yamagata, H., see Matsumura, R. (139) 48
Tuji, S., see Nagasawa, H. (139) 210 Yamauchi, H., see Ogawa, M. (139) 78
Yanagihara, T., see Hirota, N. (139) 187
Uchino, H., Smith, M.-L., Bengzon, J., Lundgren, J. and Siesjé, B.K. Yaqub, B.A.
Characteristics of postischemic seizures in hyperglycemic rats (139) Subacute sclerosing panencephalitis (SSPE): early diagnosis, prognos-
21 tic factors and natural history (139) 227
Yokoyama, M., see Tanahashi, N. (139) 137
Vanacore, R., see Bongioanni, P. (139) 71 Yonekura, Y., see Honda, M. (139) 95
Van der Kamp, W., MaassenVanDenBrink, A., Ferrari, M.D. and Yoshikawa, H., see Hirota, N. (139) 187
Van Dijk, J.G. Young, G.B., see Zifko, U.A. (139) 197
Interictal cortical hyperexcitability in migraine patients demonstrated Yuki, N. and Miyagi, F.
with transcranial magnetic stimulation (139) 106 Possible mechanism of intravenous immunoglobulin treatment on
Van Dijk, J.G., see Van der Kamp, W. (139) 106 anti-GM1 antibody-mediated neuropathies (139) 160
Van Domburg, P.H.M.F., Ten Donkelaar, H.J. and Notermans, S.L.H.
Akinetic mutism with bithalamic infarction. Neurophysiological corre-
lates (139) 58
Zifko, U.A., Slomka, P.J., Reid, R.H., Young, G.B., Remtulla, H. and
Watanabe, S., see Matsui, M. (139) 235 Bolton, C.F.
Wilcox, H.M., see Hoffman, E.K. (139) 15 The cortical representation of somatosensory evoked potentials of the
Wong, J.Y.F., see Howells, D.W. (139) 125 phrenic nerve (139) 197
JOURNAL OF THE
NEUROLOGICAL
SCIENCES
Journal of the Neurological Sciences 139 (1996) 249-250
Subject Index (Vol. 139)
Akinetic mutism, (139) 58 Encephalomyopathy, (139) 111
Alzheimer’s disease, (139) 78, 83 Energy metabolism, (139) 78
Amnesia, (139) 95 Entrapment neuropathy, (139) 187
Amyotrophic lateral sclerosis, (139) 15 Enzyme digestion, (139) 117
Anionic site, (139) 117 Erythrocyte aggregation, (139) 137
Anoxia, (139) 39 Euglobulin fraction, (139) 83
Anticipation, (139) 48 Evoked potentials, (139) 197
Anti-GM1 antibody, (139) 160 Experimental autoimmune encephalomyelitis, (139) |
Antioxidant enzyme, (139) 180 Extracellular matrix, (139) 203
Apoptosis, (139) 1
Ascending paraplegia, (139) 156
Facilitation, (139) 131
Aspirin, (139) 137
Fibrinolysis, (139) 83
Autoimmunity, (139) 235
Focal cerebral ischemia, (139) 173
Basal ganglia, (139) 218
Basic fibroblast growth factor, (139) 173 Genetic counseling, (139) 48
Behaviour, (139) 167 Genotype, (139) 52
Botulinum toxin, (139) 242 Glutamate, (139) 167
Brain atrophy, (139) 156 GYKI 52466, (139) 167
CAG repeat, (139) 52
HBs antigen, (139) 235
Calculation, (139) 89
Head tremor, (139) 242
Catechol-O-methyltransferase, (139) 141
Healthy carriers, (139) 7
Cationic colloidal gold, (139) 117
Heat shock protein, (139) 66
Cell swelling, (139) 39
Hemorheology, (139) 137
Cell viability, (139) 39
Hereditary neuropathy with liability to pressure palsies, (139) 187
Cell volume regulation, (139) 39
Hippocampus, (139) 21, 95
Central motor conduction time, (139) 131
Host, (139) 125
Cerebral arteriovenous difference, (139) 78
HTLV-I myelopathy, (139) 7
Cerebral blood flow, (139) 78
Human denervated muscle, (139) 203
Cerebral infarction, (139) 137, 173
Hydrocephalus, (139) 156
Cerebral ischemia, (139) 167
8-Hydroxy-deoxyguanosine, (139) 111
Cerebral metabolic rate of glucose, (139) 210
Hyperalgesia, (139) 28
Cerebrospinal fluid, (139) 66
Hyperglycemia, (139) 21
Cerebrospinal fluid (CSF) cytology, (139) 156
Hypermetria, (139) 238
Cholera toxin, (139) 160
Congenital toxoplasmosis, (139) 156
Contraction, (139) 48 Idiotype, (139) 160
Cortical hyperexcitability, (139) 106 Immune complex, (139) 235
Corticobasal degeneration, (139) 210 Immunofluorescence cytometry, (139) 71
Corticospinal tract, (139) 131 Immunohistochemistry, (139) 190
Corticosteroid, (139) 235 IMSA, (139) 203
CTG repeat, (139) 48 Inertial load, (139) 238
Cu/Zn superoxide dismutase, (139) 15 Injury, (139) 125
Cyclosporin A inhibition, (139) 7 Interleukin-6, (139) 7
Intermediate desmin-like filament, (139) 190
Demyelination, (139) 235 Intravenous immunoglobulin, (139) 160
Denervation, (139) 203 Intraventricular fluid, (139) 141
DNA analysis, (139) 52 Ischaemic cerebellar stroke, (139) 242
L-DOPA, (139) 141 Ischemia, (139) 21
Dopamine, (139) 125
Dopamine metabolism, (139) 210
Japanese, (139) 48
Dural microvessel, (139) 117
Electroencephalogram (EEG), (139) 21 Lectin-gold, (139) 117
Electroencephalography (EEG), (139) 227 Lymphocyte subsets, (139) 71
250 Subject Index (Vol. 139)
Machado-Joseph disease, (139) 52 Positron emission tomography, (139) 89, 210
Magnetic stimulation, (139) 106 Postischemic seizure, (139) 21
Mdx mouse, (139) 180 Prefrontal area, (139) 89
Measle virus, (139) 227 Proteasome, (139) 15
Memory, (139) 95 Proteasome inhibitor, (139) 15
Memory cells, (139) 71 Proteolytic degradation, (139) 15
Mental arithmetic, (139) 89
Mesial temporal lobe lesion, (139) 95 Rat, (139) 21, 167
Microcephaly, (139) 156 Recovery, (139) 1
Microphthalmia, (139) 156 Recurrent myelitis, (139) 235
Migraine, (139) 106 Regeneration, (139) 125
Molecular mimicry, (139) 235 Rimmed vacuole, (139) 190
Monoamine, (139) 141
Motor adaptation, (139) 218 Sensory cortex, (139) 197
Motor evoked potential, (139) 131 Single-photon emission computed tomography, (139) 78
Motor skill learning, (139) 218 Skeletal muscle, (139) 111, 180
Multiple sclerosis, (139) 71 SOD] mutations, (139) 15
Muscular dystrophy, (139) 180 Spike-and-wave discharges, (139) 58
Myelitis, (139) 156 Spinal cord potential, (139) 131
Myoclonus, (139) 227 Spinocerebellar ataxia, (139) 52
Myopathy, (139) 149 Spontaneous lymphocytic proliferation, (139) 7
Myotonic dystrophy, (139) 48 Sporadic distal myopathy, (139) 190
Stimulus—response relationship, (139) 106
Naive cells, (139) 71 Striatum, (139) 125
Neocortex, (139) 21 Subacute sclerosing panencephalitis (SSPE), (139) 227
Nerve conduction study, (139) 187 Superoxide dismutase, (139) 111
Neuro-2A neuroblastoma, (139) 39
Neuroimaging, (139) 197 T cell deletion, (139) 1
Neurolysis, (139) 28 T-cell subsets, (139) 71
Neuropathy, (139) 28 Tenascin, (139) 203
Thalamopeduncular artery, (139) 58
Oxygen /glucose utilization ratio, (139) 78 Thalamus, (139) 58
Oxygen radical, (139) 111 L-Threo-dihydroxyphenylserine, (139) 141
TNF-a, (139) 7
P300, (139) 95 Tolerance, (139) 1
Pain, (139) 28 Transcranial magnetic stimulation, (139) 131
Parkinson’s disease, (139) 66, 141, 218 Trinucleotide repeat, (139) 52
Paternal transmission, (139) 48 Tubular aggregate, (139) 149
Periodic complexes, (139) 227
Phenotype, (139) 52 Ultrastructure, (139) 190
Phrenic nerve, (139) 197 Urokinase, (139) 83
Plasma, (139) 83
Platelet, (139) 137 Vascular dementia, (139) 83
PMP-22 gene, (139) 187 Vascular headache, (139) 117
31-P MRS, (139) 149
Pontine stroke, (139) 238 Wallerian degeneration, (139) 28